Image

Primary Care Online Emotion-regulation Treatment (POET)

Recruiting
12 - 17 years of age
Both
Phase N/A

Powered by AI

Overview

Mental health problems in youth are a global problem, causing incalculable suffering in youth and families, harming long-term prospects of youths, and creating substantial economic costs to society.

The overall objective of this study is to build an evidence base for a highly scalable transdiagnostic intervention called the Primary care Online Emotion-regulation Treatment (POET) for youth (12-17 years) seeking treatment for mental health problems.

In a randomized controlled trial, the investigators will examine the effects of POET. The investigators will test if emotion regulation mediates reduction in mental health problems during treatment. In addition the investigators will test if POET is more effective for some individuals than others and evaluate if POET is cost-effective. The investigators will also test whether there are detectable effects of POET on distal outcomes utilizing registry data following participants up to 10 years post treatment.

Description

Introduction

Mental health problems among young people are prevalent and many youth in need of treatment for mental health problems do not meet criteria for any mental health disorder or they meet criteria for several disorders. Most existing treatments focus on a subset of mental disorders and do not address subthreshold or multi-disorder mental health problems. In addition, available treatments do not typically target transdiagnostic disease mechanisms. Furthermore, the available treatments are limited in efficacy and most youth in need do not receive treatment due to social stigma and structural barriers such as geographical distance to treatment providers.

The aim of this randomized clinical trial is to determine the clinical efficacy of a digital emotion regulation treatment in adolescents with mental health problems. Participants will be randomized to a digital emotion regulation treatment or to an active comparator. Treatments in both conditions will include therapist support, and will be delivered in a blended treatment format combining asynchronous therapist-guided online modules with one synchronous session delivered over video-link. The primary endpoint is at post- treatment.

Primary objectives:

  1. To test the effects of POET on mental health problems.
  2. To test the effects of POET on emotion regulation.

Secondary objectives:

  1. To test if emotion regulation mediates reductions in mental health problems during treatment.
  2. To test if POET is cost-effective.
  3. To test if POET works better for some individuals than others (i.e., moderation).
  4. To test if there are detectable differences in distal outcomes between POET and active control 12 to 60 months post treatment and if individual baseline characteristics moderates these effects.

Research questions:

  1. What are the effects of POET on mental health problems?
  2. What are the effects of POET on emotion regulation?
  3. Are reductions in mental health problems during the POET treatment mediated through emotion regulation?
  4. Is POET feeling cost-effective?
  5. Does POET work better for some individuals than others?
  6. Are there detectable differences in distal outcomes between POET and active control 12 to 60 months post treatment and if individual baseline characteristics moderates these effects

Eligibility

Inclusion Criteria:

  • Age between 12 - 17 years
  • Seeking care for mental health problems
  • At least one guardian interested in participating in the parent program
  • Deemed capable of making decisions

Exclusion Criteria:

  • Psychiatric problems that require more extensive treatment.
  • Low global functioning (under 41 points on clinician rated C-GAS or functioning that requires more extensive treatment).
  • Elevated suicide risk
  • Insufficient Swedish comprehension.
  • Life circumstances that complicate or make treatment impossible (eg severe deficits in parental care, domestic violence).

Study details

Mental Health Issue

NCT06067165

Karolinska Institutet

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.